CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,929 | -44.8% | 5,959 | -34.4% | 0.00% | – |
| Q2 2023 | $97,679 | +105.4% | 9,078 | +95.3% | 0.00% | – |
| Q1 2023 | $47,549 | +4654.9% | 4,648 | +6446.5% | 0.00% | – |
| Q3 2022 | $1,000 | -75.0% | 71 | -79.4% | 0.00% | – |
| Q2 2022 | $4,000 | -96.6% | 345 | -96.9% | 0.00% | – |
| Q1 2022 | $116,000 | -61.5% | 11,087 | -43.2% | 0.00% | – |
| Q4 2021 | $301,000 | +30000.0% | 19,509 | +34737.5% | 0.00% | – |
| Q3 2021 | $1,000 | -99.5% | 56 | -99.3% | 0.00% | – |
| Q2 2021 | $204,000 | +19.3% | 7,923 | +93.5% | 0.00% | – |
| Q1 2021 | $171,000 | – | 4,095 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |